BSE filing, NSE: PROVEST. Summary written from the filing by ALFA Finder's alert engine.
Pro Clb Global Ltd: key numbers
- Share price
- ₹48.50
- Market cap
- ₹24.75 Cr
- Revenue (annual)
- ₹1.14 Cr
- Net profit (annual)
- ₹1.00 Cr
- P/E (TTM)
- 19.6×Sector 36.4×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pro Clb Global Ltd
All →Pro Clb Global Board Meeting Date
Pro Clb Global intimated a Board meeting for November 2, 2026, to consider Q2 FY27 standalone results. No financial outcomes are reported in this advance notice.
Pro Clb Global Capacity Expansion
Pro CLB Global commenced a new business division, BNP Café, a nationwide business networking platform. It plans chapters across about 20,000 PIN code areas in phases, with no monetary amount disclosed.
- Execution
- Phased rollout, no end date stated
- proposed chapter coverage
- 20000.0 PIN code areas
Pro Clb Global Other Announcement
Pro Clb Global Limited filed a certificate confirming compliance with SEBI Regulation 74(5) regarding securities dematerialization for the quarter ended September 30, 2026.
Pro Clb Global Management Change
Pro Clb Global Limited announced the resignation of Mr. Monil Navinchandra Vora as the company's Chief Executive Officer, effective October 14, 2026.
Pro Clb Global Annual General Meeting
Pro Clb Global Ltd held its 32nd Annual General Meeting on September 30, 2026. Members adopted the financial statements and approved routine director and auditor appointments.
Pro Clb Global Capital Structure Change
Pro Clb Global has allotted 1.09 crore convertible warrants at ₹31.96 per warrant. This capital structure change increases the potential equity base of the company.
- Value
- ₹34.90 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.